Ravi Metlapally
Overview
Explore the profile of Ravi Metlapally including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heier J, Lad E, Holz F, Rosenfeld P, Guymer R, Boyer D, et al.
Immunotherapy
. 2025 Jan;
1-15.
PMID: 39819346
No abstract available.
2.
Heier J, Lad E, Holz F, Rosenfeld P, Guymer R, Boyer D, et al.
Lancet
. 2023 Oct;
402(10411):1434-1448.
PMID: 37865470
Background: Geographic atrophy is a leading cause of progressive, irreversible vision loss. The objectives of OAKS and DERBY were to assess the efficacy and safety of pegcetacoplan compared with sham...
3.
Liao D, Metlapally R, Joshi P
Immunotherapy
. 2022 Jul;
14(13):995-1006.
PMID: 35860926
What Is This Summary About?: This is a summary of a publication about the FILLY study, which was published in in 2020. The FILLY study looked at an investigational medicine...
4.
Nittala M, Metlapally R, Ip M, Chakravarthy U, Holz F, Staurenghi G, et al.
JAMA Ophthalmol
. 2022 Feb;
140(3):243-249.
PMID: 35113137
Importance: Change in areas of incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA) within eyes with geographic atrophy (GA) might reflect similar changes among eyes with drusen but...
5.
Wykoff C, Rosenfeld P, Waheed N, Singh R, Ronca N, Slakter J, et al.
Ophthalmology
. 2021 Mar;
128(9):1325-1336.
PMID: 33711380
Objectives: To evaluate clinical characteristics of eyes in which investigator-determined new-onset exudative age-related macular degeneration (eAMD) developed during the FILLY trial. Design: Post hoc analysis of the phase 2 study...
6.
Steinle N, Pearce I, Mones J, Metlapally R, Saroj N, Hamdani M, et al.
Am J Ophthalmol
. 2021 Mar;
227:116-124.
PMID: 33675755
Purpose: To evaluate the effect of select baseline characteristics on geographic atrophy (GA) progression in eyes receiving intravitreal pegcetacoplan or sham. Design: Phase 2 multicenter, randomized, single-masked, sham-controlled trial. Methods:...
7.
Metlapally R, Wildsoet C
Prog Mol Biol Transl Sci
. 2015 Aug;
134:241-8.
PMID: 26310158
In the regulation of ocular growth, scleral events critically determine eye size and thus the refractive status of the eye. Increased scleral matrix remodeling can lead to exaggerated eye growth...